EP3325468
CHK1/2 INHIBITORS FOR USE IN THE TREATMENT OF NEUROBLASTOMAS AND/OR SOFT TISSUE SARCOMAS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.7.2016EP published:
11.11.2020EP application number:
16745005.5
EPO information:
European Patent Register
Max expiry date:
14.7.2036
Title:
CHK1/2 INHIBITORS FOR USE IN THE TREATMENT OF NEUROBLASTOMAS AND/OR SOFT TISSUE SARCOMAS
Timeline
Today
15.7.2016EP application
11.11.2020EP Publication
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
STANCATO, Louis FrankAddress:
Indianapolis, Indiana 46206-6288, US
Priority
Number:
201562196087 PDate:
23.7.2015Country:
US
Number:
201562248408 PDate:
30.10.2015Country:
US
Number:
201562264059 PDate:
7.12.2015Country:
US
Classification
Categories:
C07D 403/12, A61K 31/4155, A61P 35/00